Legal
-
Court denies Pharmacor’s ‘fishing expedition’
- Fri May 29
Rejected discovery bid in the ongoing Forxiga fight tightens rules for pharma patent challenges while handing AstraZeneca a procedural victory.
Read more -
Ex-sales manager launches legal action against Novo Nordisk
- Mon May 25
Former employee alleges his complaints that Novo may have breached TGA regulations and the MA code ultimately led to his dismissal.
Read more -
Court turns up heat in AZ patent dispute
- Wed Apr 22
AstraZeneca-Pharmacor dispute over the $100M PBS dapagliflozin market deepens as the Federal Court orders then restricts disclosure.
Read more -
Guild condemns ‘shocking’ $5M PBS fraud
- Mon Mar 23
A pharmacist has pleaded guilty to 19,502 fraudulent PBS claims as the Federal Court rejects an appeal from multiple pharmacies over more PBS claims.
Read more -
Gilead loses court battle against Butler
- Fri Mar 13
Challenge to Health’s application of statutory price cuts to combination products loses, Gilead ordered to pay the Minister’s costs.
Read more -
AZ patent battle moves at lightning speed
- Mon Feb 16
High‑stakes Forxiga patent battle reaches a fast‑tracked decision with major implications for generic competitors and for AZ’s PBS income.
Read more -
Aussie pharma takes PBAC to court
- Wed Feb 11
A negative decision by the reimbursement committee has seen this local company turn to the justice system in a legal challenge to PBAC’s remit.
Read more -
Landmark case sparks David vs Goliath battle
- Wed Feb 11
OP-ED: Rarely has a company challenged PBAC in court, this case sure to be watched not just by PBS sponsors, but an army of post-menopausal women.
Read more